Relevant targets for therapy with monoclonal antibodies in allograft transplantation (Q72822633)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7967369%20AND%20SRC:MED&resulttype=core&format=json

29 October 2019

review article

1 reference

title

Relevant targets for therapy with monoclonal antibodies in allograft transplantation (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7967369%20AND%20SRC:MED&resulttype=core&format=json

29 October 2019

1 reference

J P Soulillou

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7967369%20AND%20SRC:MED&resulttype=core&format=json

29 October 2019

language of work or name

English

0 references

publication date

1 August 1994

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7967369%20AND%20SRC:MED&resulttype=core&format=json

29 October 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7967369%20AND%20SRC:MED&resulttype=core&format=json

29 October 2019

volume

46

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7967369%20AND%20SRC:MED&resulttype=core&format=json

29 October 2019

issue

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7967369%20AND%20SRC:MED&resulttype=core&format=json

29 October 2019

page(s)

540-553

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7967369%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1038/ki.1994.306

29 October 2019

exact match

0 references

cites work

Hybrid hybridomas and their use in immunohistochemistry

1 reference

https://api.crossref.org/works/10.1038%2FKI.1994.306

7 January 2021

Some effects of purified heterologous antihuman lymphocyte serum in man.

1 reference

https://api.crossref.org/works/10.1038%2FKI.1994.306

7 January 2021

A randomized clinical trial of induction therapy with OKT3 in kidney transplantation

1 reference

https://api.crossref.org/works/10.1038%2FKI.1994.306

7 January 2021

Anti-interleukin 2 receptor monoclonal antibody in the treatment of ongoing acute rejection episodes of human kidney graft--a pilot study

1 reference

https://api.crossref.org/works/10.1038%2FKI.1994.306

7 January 2021

A randomized clinical trial of OKT3 monoclonal antibody for acute rejection of cadaveric renal transplants

1 reference

https://api.crossref.org/works/10.1038%2FKI.1994.306

7 January 2021

Specific acceptance of cardiac allograft after treatment with antibodies to ICAM-1 and LFA-1

1 reference

https://api.crossref.org/works/10.1038%2FKI.1994.306

7 January 2021

Transmembrane signalling through the T-cell-receptor-CD3 complex.

1 reference

https://api.crossref.org/works/10.1038%2FKI.1994.306

7 January 2021

Treatment of acute renal allograft rejection with OKT3 monoclonal antibody

1 reference

https://api.crossref.org/works/10.1038%2FKI.1994.306

7 January 2021

Improved results using OKT3 as induction immunosuppression in renal allograft recipients with delayed graft function

1 reference

https://api.crossref.org/works/10.1038%2FKI.1994.306

7 January 2021

Influence of low-dose cyclosporine on the outcome of treatment with OKT3 for acute renal allograft rejection

1 reference

https://api.crossref.org/works/10.1038%2FKI.1994.306

7 January 2021

Does OKT3 monoclonal antibody react with an antigen-recognition structure on human T cells?

1 reference

https://api.crossref.org/works/10.1038%2FKI.1994.306

7 January 2021

Human in vivo antigenic modulation induced by the anti-T cell OKT3 monoclonal antibody.

1 reference

https://api.crossref.org/works/10.1038%2FKI.1994.306

7 January 2021

The mechanism of anti-CD3 monoclonal antibodies. Mediation of cytolysis by inter-T cell bridging

1 reference

https://api.crossref.org/works/10.1038%2FKI.1994.306

7 January 2021

OKT3-induced cytokine release attenuation by high-dose methylprednisolone

1 reference

https://api.crossref.org/works/10.1038%2FKI.1994.306

7 January 2021

Hypothermia and hypoglycemia induced by anti-CD3 monoclonal antibody in mice: role of tumor necrosis factor.

1 reference

https://api.crossref.org/works/10.1038%2FKI.1994.306

7 January 2021

In vivo induction of interleukin 10 by anti-CD3 monoclonal antibody or bacterial lipopolysaccharide: differential modulation by cyclosporin A

1 reference

https://api.crossref.org/works/10.1038%2FKI.1994.306

7 January 2021

The human immune response to the OKT3 monoclonal antibody is oligoclonal

1 reference

https://api.crossref.org/works/10.1038%2FKI.1994.306

7 January 2021

Antimurine antibody formation following OKT3 therapy

1 reference

https://api.crossref.org/works/10.1038%2FKI.1994.306

7 January 2021

Increased incidence of lymphoproliferative disorder after immunosuppression with the monoclonal antibody OKT3 in cardiac-transplant recipients

1 reference

https://api.crossref.org/works/10.1038%2FKI.1994.306

7 January 2021

Post-transplantation lymphoproliferative disorder and OKT3

1 reference

https://api.crossref.org/works/10.1038%2FKI.1994.306

7 January 2021

First clinical experience with a new TCR/CD3-monoclonal antibody (BMA 031) in kidney transplant patients

1 reference

https://api.crossref.org/works/10.1038%2FKI.1994.306

7 January 2021

Anti-CD3 F(ab')2 fragments are immunosuppressive in vivo without evoking either the strong humoral response or morbidity associated with whole mAb

1 reference

https://api.crossref.org/works/10.1038%2FKI.1994.306

7 January 2021

https://api.crossref.org/works/10.1038%2FKI.1994.306

1 reference

7 January 2021

Adhesion receptors of the immune system

1 reference

https://api.crossref.org/works/10.1038%2FKI.1994.306

7 January 2021

Lymphocyte activation and effector functions. Editorial overview. The role of cell surface molecules

1 reference

https://api.crossref.org/works/10.1038%2FKI.1994.306

7 January 2021

Lymphocyte interactions with endothelial cells

1 reference

https://api.crossref.org/works/10.1038%2FKI.1994.306

7 January 2021

Protective effects of oligosaccharides in P-selectin-dependent lung injury

1 reference

https://api.crossref.org/works/10.1038%2FKI.1994.306

7 January 2021

Prolongation of allograft and xenograft survival in mice by anti-CD2 monoclonal antibodies

1 reference

https://api.crossref.org/works/10.1038%2FKI.1994.306

7 January 2021

Prevention of graft failure by an anti-HLFA-1 monoclonal antibody in HLA-mismatched bone-marrow transplantation

1 reference

https://api.crossref.org/works/10.1038%2FKI.1994.306

7 January 2021

Induction of tolerance by monoclonal antibody therapy

1 reference

https://api.crossref.org/works/10.1038%2FKI.1994.306

7 January 2021

A phase I trial of immunosuppression with anti-ICAM-1 (CD54) mAb in renal allograft recipients

1 reference

https://api.crossref.org/works/10.1038%2FKI.1994.306

7 January 2021

An alternative pathway of T-cell activation: A functional role for the 50 kd T11 sheep erythrocyte receptor protein

1 reference

https://api.crossref.org/works/10.1038%2FKI.1994.306

7 January 2021

Enhancement of LFA-1-mediated cell adhesion by triggering through CD2 or CD3 on T lymphocytes

1 reference

https://api.crossref.org/works/10.1038%2FKI.1994.306

7 January 2021

Anti-CD2 monoclonal antibodies alter cell-mediated immunity in vivo

1 reference

https://api.crossref.org/works/10.1038%2FKI.1994.306

7 January 2021

Molecules involved in T-cell costimulation

1 reference

https://api.crossref.org/works/10.1038%2FKI.1994.306

7 January 2021

Costimulation of T lymphocytes: the role of CD28, CTLA-4, and B7/BB1 in interleukin-2 production and immunotherapy

1 reference

https://api.crossref.org/works/10.1038%2FKI.1994.306

7 January 2021

Immunosuppression in vivo by a soluble form of the CTLA-4 T cell activation molecule

1 reference

https://api.crossref.org/works/10.1038%2FKI.1994.306

7 January 2021

Molecular biology and function of CD4 and CD8

1 reference

https://api.crossref.org/works/10.1038%2FKI.1994.306

7 January 2021

Coclustering CD45 with CD4 or CD8 alters the phosphorylation and kinase activity of p56lck

1 reference

https://api.crossref.org/works/10.1038%2FKI.1994.306

7 January 2021

Anti-CD4 mediates clonal anergy during transplantation tolerance induction

1 reference

https://api.crossref.org/works/10.1038%2FKI.1994.306

7 January 2021

Tolerance to rat monoclonal antibodies. Implications for serotherapy

1 reference

https://api.crossref.org/works/10.1038%2FKI.1994.306

7 January 2021

"Infectious" transplantation tolerance.

1 reference

https://api.crossref.org/works/10.1038%2FKI.1994.306

7 January 2021

OKT4 and OKT4A antibody treatment as immunosuppression for kidney transplantation in rhesus monkeys

1 reference

https://api.crossref.org/works/10.1038%2FKI.1994.306

7 January 2021

Anti-CD4 monoclonal antibody administration in renal transplanted patients

1 reference

https://api.crossref.org/works/10.1038%2FKI.1994.306

7 January 2021

Nonhuman primate responses to murine and humanized OKT4A.

1 reference

https://api.crossref.org/works/10.1038%2FKI.1994.306

7 January 2021

Evidence that anti-CD8 abrogates anti-CD4-mediated clonal anergy but allows allograft survival in mice.

1 reference

https://api.crossref.org/works/10.1038%2FKI.1994.306

7 January 2021

Immunosuppression by anti-CD4 treatment in vivo. Persistence of secondary antiviral immune responses.

1 reference

https://api.crossref.org/works/10.1038%2FKI.1994.306

7 January 2021

T cell growth factor receptors. Quantitation, specificity, and biological relevance

1 reference

https://api.crossref.org/works/10.1038%2FKI.1994.306

7 January 2021

Only high-affinity receptors for interleukin 2 mediate internalization of ligand

1 reference

https://api.crossref.org/works/10.1038%2FKI.1994.306

7 January 2021

Novel interleukin-2 receptor subunit detected by cross-linking under high-affinity conditions

1 reference

https://api.crossref.org/works/10.1038%2FKI.1994.306

7 January 2021

Cloning of the gamma chain of the human IL-2 receptor

1 reference

https://api.crossref.org/works/10.1038%2FKI.1994.306

7 January 2021

Sharing of the interleukin-2 (IL-2) receptor gamma chain between receptors for IL-2 and IL-4

1 reference

https://api.crossref.org/works/10.1038%2FKI.1994.306

7 January 2021

Interleukin-2 receptor gamma chain mutation results in X-linked severe combined immunodeficiency in humans

1 reference

https://api.crossref.org/works/10.1038%2FKI.1994.306

7 January 2021

Development and function of T cells in mice rendered interleukin-2 deficient by gene targeting

1 reference

https://api.crossref.org/works/10.1038%2FKI.1994.306

7 January 2021

Administration of an anti-interleukin 2 receptor monoclonal antibody prolongs cardiac allograft survival in mice

1 reference

https://api.crossref.org/works/10.1038%2FKI.1994.306

7 January 2021

Prolongation of primate renal allograft survival by anti-Tac, an anti-human IL-2 receptor monoclonal antibody

1 reference

https://api.crossref.org/works/10.1038%2FKI.1994.306

7 January 2021

Anti-interleukin 2 receptor monoclonal antibodies. Respective role of epitope mapping and monoclonal antibody-receptor interactions in their antagonist effects on interleukin 2-dependent T cell growth

1 reference

https://api.crossref.org/works/10.1038%2FKI.1994.306

7 January 2021

Parameters of interaction of a novel monoclonal antibody (33B3.1) with the human IL2-receptors: interrelationship between 33B3.1, anti-Tac, and IL2 binding sites

1 reference

https://api.crossref.org/works/10.1038%2FKI.1994.306

7 January 2021

Prevention of rejection of kidney transplants by monoclonal antibody directed against interleukin 2.

1 reference

https://api.crossref.org/works/10.1038%2FKI.1994.306

7 January 2021

Randomized controlled trial of a monoclonal antibody against the interleukin-2 receptor (33B3.1) as compared with rabbit antithymocyte globulin for prophylaxis against rejection of renal allografts

1 reference

https://api.crossref.org/works/10.1038%2FKI.1994.306

7 January 2021

Prevention of acute rejection episodes with an anti-interleukin 2 receptor monoclonal antibody. II. Results after a second kidney transplantation

1 reference

https://api.crossref.org/works/10.1038%2FKI.1994.306

7 January 2021

Prevention of acute rejection episodes with an anti-interleukin 2 receptor monoclonal antibody. I. Results after combined pancreas and kidney transplantation

1 reference

https://api.crossref.org/works/10.1038%2FKI.1994.306

7 January 2021

A randomized prospective trial of anti-Tac monoclonal antibody in human renal transplantation

1 reference

https://api.crossref.org/works/10.1038%2FKI.1994.306

7 January 2021

Comparison of quadruple immunosuppression after liver transplantation with ATG or IL-2 receptor antibody.

1 reference

https://api.crossref.org/works/10.1038%2FKI.1994.306

7 January 2021

A humanized antibody that binds to the interleukin 2 receptor

1 reference

https://api.crossref.org/works/10.1038%2FKI.1994.306

7 January 2021

Characterization of the CAMPATH-1 (CDw52) antigen: biochemical analysis and cDNA cloning reveal an unusually small peptide backbone

1 reference

https://api.crossref.org/works/10.1038%2FKI.1994.306

7 January 2021

Campath-1M--prophylactic use after kidney transplantation. A randomized controlled clinical trial

1 reference

https://api.crossref.org/works/10.1038%2FKI.1994.306

7 January 2021

EFFECT OF GRAFT PERFUSION WITH TWO CD45 MONOCLONAL ANTIBODIES ON INCIDENCE OF KIDNEY ALLOGRAFT REJECTION

1 reference

https://api.crossref.org/works/10.1038%2FKI.1994.306

7 January 2021

Human lymphocyte antigens: production of a monoclonal antibody that defines functional thymus-derived lymphocyte subsets

1 reference

https://api.crossref.org/works/10.1038%2FKI.1994.306

7 January 2021

Preparation of bispecific antibodies by chemical recombination of monoclonal immunoglobulin G1 fragments

1 reference

https://api.crossref.org/works/10.1038%2FKI.1994.306

7 January 2021

The role of antibody isotype in IFN-gamma and IL-2 production during anti-CD3-induced T cell proliferation

1 reference

https://api.crossref.org/works/10.1038%2FKI.1994.306

7 January 2021

Prevention of lung reperfusion injury in rabbits by a monoclonal antibody against interleukin-8.

1 reference

https://api.crossref.org/works/10.1038%2FKI.1994.306

7 January 2021

Characterization of ICAM-2 and evidence for a third counter-receptor for LFA-1

1 reference

https://api.crossref.org/works/10.1038%2FKI.1994.306

7 January 2021

Identifiers

DOI

10.1038/KI.1994.306

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7967369%20AND%20SRC:MED&resulttype=core&format=json

29 October 2019

1 reference